Assyro AI

Orange Book product · Generic (ANDA)

TOPOTECAN HYDROCHLORIDE

TOPOTECAN HYDROCHLORIDE

Generic (ANDA)ANDA 206074DISCN NATCO PHARMA USA

At a glance

Nov 24, 2017

Approved

Generic (ANDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Nov 24, 2017

    8 yr 8 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

TOPOTECAN HYDROCHLORIDE

Strength

EQ 4MG BASE/4ML (EQ 1MG BASE/ML)

Dosage form

SOLUTION

Route

INTRAVENOUS

TE code

Not listed

Application

ANDA 206074

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of TOPOTECAN HYDROCHLORIDE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.